Annual report pursuant to Section 13 and 15(d)

Stock-based Payments (Tables)

v3.24.1
Stock-based Payments (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options Activity

The following table summarizes the activities for MyMD stock options for the year ended December 31, 2023:

 

                      Weighted        
                      Average        
          Weighted     Weighted     Remaining        
    Number     Average     Average     Contractual     Aggregate  
    of     Exercise     Grant Date     Term     Intrinsic  
    Shares     Price     Fair Value     (years)     Value  
Balance at December 31, 2022     149,241     $ 79.34     $ 78.64       0.64     $     -  
Granted     129,838       41.77       38.53       8.45     $ -  
Exercised     -       -       -       -       -  
Forfeited     -       -       -       -       -  
Canceled/Expired     (139,239 )     77.70       77.70       -       -  
Balance at December 31, 2023     139,840       46.09       42.34       8.17     $ -  
Exercisable as of December 31, 2023     47,286       56.44       51.49       7.48     $ -  
Summary of Restricted Stock Units Activity

The following is the status of outstanding unvested restricted stock units outstanding as of December 31, 2023 and the changes for the year ended December 31, 2023:

 Summary of Restricted Stock Units Activity

          Weighted  
          Average  
    Number of     Grant Date  
    RSUs     Fair Value  
Balance at December 31, 2022     93,169     $ 242.70  
Granted     -       -  
Vested     -       -  
Forfeited     -       -  
Canceled/Expired     (4,501 )     242.70  
Balance at December 31, 2023     88,668     $ 242.70